摘要
Hyperlipidemia, a common metabolic disease, is a risk factor for cardiovascular diseases, Poria cocos (PC) and Alismatis rhizoma (AR) serve as a potential treatment. A systematic approach based on transcriptome sequencing analysis and bioinformatics methods was developed to explore the synergistic effects of PC-AR and identify major compounds and potential targets. The phenotypic characteristics results indicated that the high dose (4.54 g/kg) of PC-AR reduced total cholesterol (TC), elevated high-density lipoprotein cholesterol (HDL-C) levels, and improved hepatocyte morphology, as assessed via hematoxylin and eosin (H&E) staining. Transcriptomic profiling processing results combined with GO enrichment analysis to identify the overlapping genes were associated with inflammatory responses. The cytokine-cytokine receptor interaction pathway was found as a potential key pathway using geneset enrichment analysis. Core enrichment targets were selected according to the PC-AR's fold change versus the model. Real-time quantitative PCR analysis validated that PC-AR significantly downregulated the expression of Cxcl10, Ccl2, Ccl4, Cd40 and Il-1 beta mRNA (P < 0.05). Molecular docking analysis revealed the significant compounds of PC-AR and the potential binding patterns of the critical compounds and targets. This study provides further evidence that the therapeutic effects of PC-AR on hyperlipidemia in rats through the regulation of inflammation-related targets.
学科与关键词
- Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network PharmacologyGong, Zhaohui; Li, Rong; Chen, Shulin; Wu, Hui; Cai, Yinhe; Li, Junlong; Zhao, Xinjun; Chu, Qingmin; Luo, Chuanjin; Qing, Lijin; Li, Nan*; Wu, Wei*Journal of Healthcare Engineering, 2022, 2022: 2457706.被引 2
- Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular DockingWang, Hui; Wang, Hua; Zhang, Jin; Luo, Jiahui; Peng, Caidong; Tong, Xiaoyun*; Chen, XudongEvidence-based Complementary and Alternative Medicine, 2022, 2022: 4891370.被引 5
- Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARa-SREBPs pathwayHe, Jinbiao; Yang, Yu; Zhang, Fan; Li, Yanjuan; Li, Xiaosi; Pu, Xuemei; He, Xudong; Zhang, Mei; Yang, Xinxing; Yu, Qiuman; Qi, Yan*; Li, Xuefang*; Yu, Jie*Frontiers in Pharmacology, 2022, 13: 1007274.被引 7
